论文部分内容阅读
目的:研究应用蔗糖铁治疗肾性贫血的效果,探讨其临床价值。方法:回顾肾性贫血患者100例,将其分成实验组52例,对照组48例,为实验组患者静脉注射蔗糖铁,要求对照组患者口服琥珀酸亚铁,对比两组患者治疗8周后的血清转铁蛋白饱和度(TSAT)、红细胞压积(HCT)、血清铁蛋白(SF)、血红蛋白(Hb)以及治疗总有效率。结果:从各项指标角度看,实验组患者的TSAT、HCT、SF、Hb明显高于对照组;从治疗有效率角度看,对照组为62.50%,实验组为86.54%,两组组数据可见显著差异,认为存在统计学意义(P<0.05),实验组患者肾性贫血的治疗效果更佳。结论:为肾性贫血患者静脉注入蔗糖铁,可提高其TSAT、HCT、SF、Hb,改善其生活质量,可在临床上进一步应用该治疗方法。
Objective: To study the effect of applying sucrose iron on renal anemia and to explore its clinical value. Methods: One hundred patients with renal anemia were retrospectively divided into experimental group (n = 52) and control group (n = 48). The patients in the experimental group were given sucrose iron intravenously and the control group were given oral ferrous succinate. After 8 weeks of treatment, (TSAT), hematocrit (HCT), serum ferritin (SF), hemoglobin (Hb), and total effective rate of treatment. Results: The TSAT, HCT, SF and Hb in the experimental group were significantly higher than those in the control group from the point of view of each index. From the point of view of effective treatment, the control group was 62.50% and the experimental group was 86.54% Significant differences, that there is a statistically significant (P <0.05), the experimental group of patients with renal anemia better treatment effect. Conclusion: Intravenous injection of sucrose iron for patients with renal anemia can improve TSAT, HCT, SF, Hb and improve their quality of life. The treatment can be further applied clinically.